Bevacizumab as a treatment for hereditary hemorrhagic telangiectasia in children: a case report. Colomb Med [Internet]. 2017 Jun. 30 [cited 2025 Dec. 31];48(2):88-93. Available from: https://colombiamedica.univalle.edu.co/index.php/comedica/article/view/2719